News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Smith Cynthia
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2023 |
4
| Smith Cynthia (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Exercised 2,302 restricted stock units
@ $0 |
|
| 06/08/2023 |
4
| Smith Cynthia (Director) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.85, valued at
$28.5k
|
|
| 06/08/2023 |
4
| Smith Cynthia (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 45,000 options to buy
@ $1.2, valued at
$54k
|
|
| 09/19/2022 |
4
| Smith Cynthia (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2021 |
4
| Smith Cynthia (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $14.76, valued at
$369k
Disposed/sold 25,000 options to buy
@ $15.44, valued at
$386k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 08/18/2021 |
4
| Smith Cynthia (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $13.69, valued at
$102.7k
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/06/2021 |
4
| Smith Cynthia (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 2,629 options to buy
@ $17.93, valued at
$47.1k
|
|
| 10/27/2020 |
4
| Smith Cynthia (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $13.52, valued at
$101.4k
|
|
| 06/16/2020 |
4
| Smith Cynthia (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 3,333 restricted stock units
@ $0
Granted 15,000 options to buy
@ $21.61, valued at
$324.2k
|
|
| 06/09/2020 |
4
| Smith Cynthia (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Sold 4,567 shares
@ $12.1, valued at
$55.3k
Granted 20,100 options to buy
@ $11.96, valued at
$240.4k
|
|
| 11/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| Smith Cynthia (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 25,000 options to buy
@ $15.44, valued at
$386k
|
|
| 06/10/2019 |
4
| Smith Cynthia (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 13,700 shares
@ $0
Granted 20,100 options to buy
@ $4.23, valued at
$85k
|
|
| 06/05/2019 |
4
| Smith Cynthia (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 6,073 options to buy
@ $10.67, valued at
$64.8k
|
|
| 03/29/2019 |
4
| Smith Cynthia (Director) has filed a Form 4 on Spero Therapeutics, Inc.|
Txns:
| Granted 12,146 options to buy
@ $12.81, valued at
$155.6k
|
|
| 03/19/2019 |
3
| Smith Cynthia (Director) has filed a Form 3 on Spero Therapeutics, Inc. |
| 08/29/2018 |
4
| Smith Cynthia (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $8.25, valued at
$206.3k
|
|
| 08/29/2018 |
3
| Smith Cynthia (Director) has filed a Form 3 on Akebia Therapeutics, Inc. |
| 08/15/2018 |
4
| Smith Cynthia (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 25,000 options to buy
@ $14.76, valued at
$369k
|
|
| 08/15/2018 |
3
| Smith Cynthia (Director) has filed a Form 3 on Dicerna Pharmaceuticals Inc |
| 11/04/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|